Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06072339
Other study ID # RECHMPL22_0556
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 19, 2023
Est. completion date November 7, 2024

Study information

Verified date December 2023
Source University Hospital, Montpellier
Contact David CHAPEAU, Physiotherapist
Phone 0467332688
Email d-chapeau@chu-montpellier.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an open-label, randomized controlled study comparing two non-invasive ventilation initiation strategies.Patients may be included if they present with acute respiratory failure related to blunt chest trauma.The intervention group will benefit from the use by the physiotherapist of pulmonary ultrasound for the adjustment of Positive End Expiratory Pressure (PEEP) during the 1st session. The conventional group will benefit from the non-invasive ventilation according to the current care.


Description:

This is an open-label, randomized controlled study comparing two non-invasive ventilation initiation strategies. Patients may be included if they are admitted to intensive care unit or continuing care unit and present with acute respiratory failure related to blunt chest trauma. We will not include patients with another indication for non-invasive ventilation, immediately needing invasive ventilation, a contraindication to non invasive ventilation or an estimated length of stay less than or equal to 48 hours. Both groups will be treated with non-ivasive ventilation according to the medical prescription. The intervention group will benefit from the use by the physiotherapist of pulmonary ultrasound for the adjustment of PEEP during the 1st session. The conventional group will benefit from the non-invasive ventilation according to the usual care. The other non-invasive ventilation settings will be chosen with the same method in both groups. The main endpoint will be the PaO2/FiO2 ratio (Arterial oxygen pressure / inspired fraction of oxygen) after 30 min of non-invasive ventilation treatment. This ratio is the best reflection of the patient oxygenation and currently used for respiratory therapies studies.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date November 7, 2024
Est. primary completion date November 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients aged 18 or more - Admitted to intensive care or continuing care for 72 hours or less for blunt chest trauma, defined by the presence of at least one of the following elements on the initial CT scan: fracture(s) of rib(s) / fracture(s) of the sternum / pulmonary contusion / hemothorax - Acute hypoxemic respiratory failure defined by the administration of oxygen at least 3 L/min with nasal cannula or FiO2=30% if high flow oxygen therapy. - Patient with a functional arterial catheter for blood tests Exclusion Criteria: - Acute respiratory distress, defined by the presence of at least one of the following clinical signs: respiratory rate ? 35 / use of accessory inspirators / paradoxal abdominal or thoracic motion - Imminent need for invasive mechanical ventilation - Usual contraindication to non-invasive ventilation (undrained pneumothorax, trauma to the face, vigilance disorders, digestive bleeding, hemodynamic instability, intolerance) - Hypercapnia (PaCO2?45mmHg) - Patient unable to cooperate, communicate - Therapeutic limitation - Expected length of stay = 48h - Severe head trauma - Pregnant or breastfeeding women - Participation in other clinical research related to respiratory failure/respiratory therapy - Vulnerable people - Protected adults, under guardianship or curatorship, or unable to give consent - Non-affiliated person or beneficiary of a social security scheme - Absence of free, informed and written consent, signed by the participant and the investigator

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Lung Ultrasound for PEEP setting
NIV is started and adjusted by the physiotherapist. For the adjustment of PEEP, the ultrasound probe is placed on the thorax, facing the intercostal space having obtained the highest score during the initial LUS (synonym of the worst pulmonary aeration) and the images observed in real time. PEEP is increased until the physiotherapist cannot see any additional benefit on pulmonary aeration or appearance of a patient discomfort or an increasing of air leaks.
Procedure:
Non invasive ventilation session
The session will be done via a mouthpiece preferably, or a face mask if it is impossible for the patient to close their mouth properly or to hold the mouthpiece. The duration of the NIV session will be defined by the prescribing doctor (usually between 30 and 60 minutes), without being able to be less than 30 minutes. The session will be stopped in the event of the appearance of one of the contraindications to NIV mentioned above.
Biological:
Arterial blood gas
Arterial blood gas will be done at inclusion, at Visit 1 (at the 30th minute from the start of the 1st Non-invasive ventilation session) and at Visit 2 (at the 60th minute from the start of the 1st Non-invasive ventilation session) in both groups of patients in order to calculate the Pa02/Fi02 ratio.
Other:
Interview on pain and comfort
The investigator physiotherapist interviews the participant to measure pain and comfort scores using a visual analogue scale (score from 0 to 10).

Locations

Country Name City State
France UH of Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary PaO2/FiO2 ratio (Arterial oxygen pressure / inspired oxygen fraction) in both groups PaO2/FiO2 ratio (Arterial oxygen pressure / inspired oxygen fraction) in both groups.
This PaO2/FiO2 ratio is now the benchmark for qualifying the severity of the respiratory impairment or measuring the response to a mechanical ventilation strategy aimed at improving oxygenation.
at the 30th minute from the start of the 1st Non-invasive ventilation session
Secondary Comparaison of the Lung Ultrasound Score (LUS) in both groups Comparaison of the Lung Ultrasound Score (LUS) in both groups. The LUS ranges from 0 to 36. Rib cage is divided into 12 areas (6 for each side) and each area is assessed according to the following scale:
0: Normal aeration corresponding to presence of lung sliding with A lines or fewer than two isolated B lines
Moderate loss of lung aeration corresponding to multiple well-defined B lines or spaced ultrasound lung called 'cornet-tail artifact"
Severe loss of lung aeration corresponding to multiple coalescent B lines or multiple abutting ultrasound lung cornet-tails issued from the pleural line
Lung consolidation corresponding to presence of a tissue pattern containing hyperechoic punctiform images representative of air bronchograms. Presence or absence of regional pulmanory blood flow and/or dynamic bronchograms.
at the 30th minute from the start of the 1st Non-invasive ventilation session
Secondary Comparaison of the PEEP value set at the start of the non-invasive ventilation session Comparaison of the PEEP value set (in cmH2O) in both groups At the start of the non-invasive ventilation session
Secondary Comparaison of the confort value in both groups Comparaison of the confort value in both groups using the Confort Visual Analog scale (from 0 to 10) at the 30th minute from the start of the 1st Non-invasive ventilation session
Secondary Comparaison of the pain value in both groups Comparaison of the pain value in both groups using the Pain Visual Analog scale (from 0 to 10) at the 30th minute from the start of the 1st Non-invasive ventilation session
Secondary Comparaison of the PaO2/FiO2 ratio in both groups Comparaison of the PaO2/FiO2 ratio in both groups 1 hour after the end of the 1st non-invasive ventilation session
Secondary Comparaison of the incidence rate of respiratory aggravation in the 2 groups Comparaison of the incidence rate of respiratory aggravation in the 2 groups Until discharge from intensive care/continuous care or until maximum D7.
Secondary Rate of patients included in the experimental group in whom the use of ultrasound during the initiation of non-invasive ventilation is possible Rate of patients included in the experimental group in whom the use of ultrasound during the initiation of NIV is possible at the 30th minute from the start of the 1st Non-invasive ventilation session
Secondary PaO2/FiO2 ratio in both groups in patients with pulmonary consolidation PaO2/FiO2 ratio in both groups in patients with pulmonary consolidation at the 30th minute from the start of the 1st Non-invasive ventilation session
Secondary PaO2/FiO2 ratio in both groups in patients with pleural effusion PaO2/FiO2 ratio in the 2 groups in patients with pleural effusion at the 30th minute from the start of the 1st Non-invasive ventilation session
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05756387 - Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
Not yet recruiting NCT06259565 - Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults Phase 3
Completed NCT02973373 - MRI of the Chest Under High Frequency Ventilation N/A
Recruiting NCT04054622 - Patient-ventilator Asychrony During Non-invasive Ventilation When COPD Patients Doing Exercise
Completed NCT03859947 - High-flow Nasal Cannula Flow Rates, Severe Bronchiolitis
Completed NCT03149835 - NIV Reduces CBF in COPD Patients Without Cognitive Function N/A
Recruiting NCT04036175 - Comparison of Patient Work of Breathing and Tidal Volumes With High Flow Nasal Cannula Oxygen Therapy and NIV (Non-Invasive Ventilation) After Extubation in the ICU. N/A
Recruiting NCT02712190 - Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation. N/A
Not yet recruiting NCT05435183 - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving Carbon Dioxide Clearance in AECOPD Patients N/A
Recruiting NCT05796297 - Clinical Impact of Patient-ventilator Asynchrony
Not yet recruiting NCT05850195 - Assessment Of Different Indices in Prediction of Noninvasive Ventilation Failure in Patients With Acute Respiratory Failure
Not yet recruiting NCT05448417 - Exploration of Non-invasive High-frequency Oscillations in Human-machine Asynchrony in Healthy Subjects N/A
Completed NCT05031650 - Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room N/A
Completed NCT03130361 - Wearable Noninvasive Positive Pressure Ventilation Device in COPD N/A
Completed NCT04178694 - The Influence of Non-invasive Ventilation on Metabolism in Healthy Volunteers N/A
Not yet recruiting NCT05721833 - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving CO2 Clearance in COPD Patients N/A
Not yet recruiting NCT05706467 - The Difference Between Non-invasive High-frequency Oscillatory Ventilation and Non-invasive Continuous Airway Pressure Ventilation in COVID-19 With Acute Hypoxemia N/A
Recruiting NCT01961245 - Effects of Nocturnal Non-invasive Ventilation on Energy Expenditure in Patients With Severe Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT03978221 - Tissue Doppler Ultrasound During Spontaneous Breathing and Non-invasive Ventilation in the Post-extubation Period. N/A
Completed NCT04884828 - Asynchronies in NIV With External Gas